- Current Scenario of Startups in India - June 26, 2019
- Why Major Financial Companies Avoid the Crypto Market - November 12, 2018
- Kaspersky Lab Reveals Scary Truths About Cybercrime and Cryptocurrency - September 21, 2018
Jeff Bezos is exploring all the possible segments of the upcoming generation. From E commerce to Space, his investments in the private equity has the variance from Bio Technology to Space Research. Recently Unity Biotechnology a startup focusing on medicines to help us do that by slowing the effects of age-related diseases, has raised $116 Mn in Series B. As reported in TechCrunch some of the money came from Jeff Bezos himself.
Unity Biotechnology helps preventing your body to age fast. Their initial focus is on selectively eliminating senescent cells.Cellular senescence is a biological “emergency brake” cells use to stop dividing. It’s an important anti-tumour mechanism, because it prevents cells from multiplying out of control. But after this “brake” has been pulled, senescent cells remain in the body, accumulating with age. And unlike normal cells, these cells secrete inflammatory molecules that harm neighbouring cells and tissues.
UNITY has demonstrated in animal models that selectively eliminating senescent cells reverses or prevents a wide range of diseases, including osteoarthritis, atherosclerosis, eye diseases, and kidney diseases.